Compositions and methods for detecting EGFR mutations in cancer

Details for Australian Patent Application No. 2009234389 (hide)

Owner Cell Signaling Technology, Inc.

Inventors Wieler, James; Kane, Susan; Haack, Herbert; Cai, Jun-Ming; Rimkunas, Victoria; Gu, Ting-Lei; Yu, Jian; Wu, Jiong

Agent Spruson & Ferguson

Pub. Number AU-A-2009234389

PCT Pub. Number WO2009/126306

Priority 61/123,699 10.04.08 US; 61/190,597 29.08.08 US

Filing date 10 April 2009

Wipo publication date 15 October 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/126306 Priority application(s): WO2009/126306

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009234390-Factor VII polypeptides that are modified and uses thereof

2009234386-Assay apparatuses, methods and reagents